Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation ; day:21 ; month:6 ; year:2023 ; pages:1-7
Strahlentherapie und Onkologie ; (21.6.2023), 1-7
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00066-023-02104-7
- URN
-
urn:nbn:de:101:1-2023092210061914485135
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Moll, Matthias
- Goldner, Gregor
- SpringerLink (Online service)
Ähnliche Objekte (12)
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
Normofractionated and moderately hypofractionated proton therapy : Comparison of acute toxicity and early quality of life outcomes
Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma
Long-term outcomes of moderately hypofractionated radiotherapy (67.5 Gy in 25 fractions) for prostate cancer confined to the pelvis: a single center retrospective analysis
Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study “GUNMA0702”
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE)
Normal tissue toxicity after small field hypofractionated stereotactic body radiation
Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for locally advanced pancreatic ductal adenocarcinoma
Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation
Acute toxicity profile in prostate cancer with conventional and hypofractionated treatment
Correction: Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for locally advanced pancreatic ductal adenocarcinoma
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
Normofractionated and moderately hypofractionated proton therapy : Comparison of acute toxicity and early quality of life outcomes
Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma
Long-term outcomes of moderately hypofractionated radiotherapy (67.5 Gy in 25 fractions) for prostate cancer confined to the pelvis: a single center retrospective analysis
Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study “GUNMA0702”
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE)
Normal tissue toxicity after small field hypofractionated stereotactic body radiation
Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for locally advanced pancreatic ductal adenocarcinoma
Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation
Acute toxicity profile in prostate cancer with conventional and hypofractionated treatment
Correction: Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for locally advanced pancreatic ductal adenocarcinoma
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
Normofractionated and moderately hypofractionated proton therapy : Comparison of acute toxicity and early quality of life outcomes
Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma
Long-term outcomes of moderately hypofractionated radiotherapy (67.5 Gy in 25 fractions) for prostate cancer confined to the pelvis: a single center retrospective analysis
Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study “GUNMA0702”
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE)
Normal tissue toxicity after small field hypofractionated stereotactic body radiation
Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for locally advanced pancreatic ductal adenocarcinoma
Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation
Acute toxicity profile in prostate cancer with conventional and hypofractionated treatment